A Practical Approach to the Evaluation of a Cardio-Oncology Patient -- Cardiac Dysfunction: Traditional Chemotherapy, Human Epidermal Growth Factor Receptor 2–Based Therapy, and Radiation -- Cardiac Dysfunction: Small-Molecule Kinase Inhibitors, Immune-Based Therapies, and Proteasome Inhibitors -- Valvular Heart Disease -- Vascular Disease in Cardio-Oncology -- Evaluation for Ischemic Heart Disease in Cardio-Oncology -- Pericardial Diseases in Malignancy -- Cancer-Associated Thrombosis and Embolism -- Cardiac Masses -- Hypertension -- Arrhythmias -- Intravascular Devices and Thrombotic Complications -- Autonomic Dysfunction -- Echo Techniques for Cardiac Safety During and After Cancer Treatment -- Biomarkers as a Tool For Cardiac Safety -- MRI Techniques to Monitor Cardiac Safety During and After Cancer Treatment -- Cancer Survivorship: Adverse Outcomes and Other Long-term Cardiovascular Considerations -- Hematopoietic Cell Transplantation -- Drug-Drug Interactions and the importance of a PharmD -- Permissive Cardiotoxicity -- Multidisciplinary Approach to Cardio-Oncology and the Use of Advanced Practice Provider -- Cardiac Amyloidosis: General Diagnostic Approach -- Light Chain Amyloidosis: Latest Treatment Strategies -- Cardiac Amyloidosis: Latest Treatment Strategies for Transthyretin Amyloidosis -- Cancer Survivors and Advanced Heart Failure Therapies